Prospective Randomized Evaluation of a new Formulation: Efficacy of Rotigotine

Trial Profile

Prospective Randomized Evaluation of a new Formulation: Efficacy of Rotigotine

Completed
Phase of Trial: Phase III

Latest Information Update: 12 Feb 2016

At a glance

  • Drugs Rotigotine (Primary)
  • Indications Parkinson's disease
  • Focus Therapeutic Use
  • Acronyms PREFER
  • Most Recent Events

    • 12 Feb 2016 Results of pooled post-hoc analysis of this and two other trials (see profile 26754 and 10814) published in the Clinical Neuropharmacology
    • 20 Apr 2015 Post-hoc analysis on pooled data presented at the 67th Annual Meeting of the American Academy of Neurology (AAN), according to a UCB media release.
    • 26 Apr 2012 Results presented at the 64th Annual Meeting of the American Academy of Neurology, according to a UCB media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top